| Ms Paula Jeanne Ledoux, RN | |
|
714 Calle Don Diego, Espanola, NM 87532-3414 | |
| (505) 367-3342 | |
| (505) 747-0936 |
| Full Name | Ms Paula Jeanne Ledoux |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 714 Calle Don Diego, Espanola, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124146972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R44560 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Paula Jeanne Ledoux, RN Po Box 3227, Santa Fe, NM 87501-0227 Ph: (505) 753-2256 | Ms Paula Jeanne Ledoux, RN 714 Calle Don Diego, Espanola, NM 87532-3414 Ph: (505) 367-3342 |
News Archive
A fundamental principle of medicine is: "first, do no harm." However, for doctors who treat breast cancer, this is easier said than done. Every year, almost 22,000 Canadian women are diagnosed with breast cancer - their treatment usually involves surgery to remove a tumour and then chemotherapy to reduce the risk of cancer returning.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
A new interventional radiology treatment, prostatic artery embolization, may bring hope to men with debilitating symptoms caused by an enlarged prostate, say the group of researchers who pioneered its use.
› Verified 2 days ago
Ruby Jean Trujillo, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1260 Industrial Park Rd, Espanola, NM 87532 Phone: 505-753-2391 | |
Rebecca Anne Romero, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1260 Industrial Park Rd, Espanola, NM 87532 Phone: 505-753-3213 Fax: 505-747-3772 | |
Marisa Anaya, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 420 N Coronado Ave, Espanola, NM 87532 Phone: 505-753-2256 | |
Melanie Trujillo, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1227 N Railroad Ave, Espanola, NM 87532 Phone: 505-747-8187 | |
Destini Rae Gomez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1227 N Railroad Ave Ste C, Espanola, NM 87532 Phone: 505-747-8187 | |
Mr. Rudy Brown, NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 104 Los Alamos Hwy, Espanola, NM 87532 Phone: 505-747-8187 Fax: 505-747-8306 |